Copyright: ©Author(s) 2026.
World J Clin Cases. Jun 6, 2026; 14(16): 119700
Published online Jun 6, 2026. doi: 10.12998/wjcc.v14.i16.119700
Published online Jun 6, 2026. doi: 10.12998/wjcc.v14.i16.119700
Table 2 Certainty of evidence using the Grades of Recommendation, Assessment, Development and Evaluation approach
| Outcomes | Anticipated absolute effects (95%CI) | n of participants (studies) | Certainty of the evidence (GRADE) | Comments |
| Liquid levothyroxine | ||||
| Thyroid-stimulating hormone | SMD 0.91 lower (1.52 lower to 0.3 lower) | 1115 (9 studies) | Lowa,b | Liquid levothyroxine may lead to a greater reduction in thyroid-stimulating hormone levels compared to tablet levothyroxine, but the evidence is uncertain |
| T4 levels | SMD 0.34 higher (0.15 higher to 0.52 higher) | 480 (5 studies) | Moderatea | Liquid levothyroxine probably results in slightly higher circulating T4 levels compared to tablet levothyroxine |
| T3 levels | SMD 0.25 higher (0.06 higher to 0.44 higher) | 432 (4 studies) | Moderatea | Liquid levothyroxine probably results in slightly higher T3 levels compared to tablet levothyroxine |
- Citation: Farhan M, Patel T, Obais MAHN, Taslimi H, Hanif M, Khalid K, Qaqour A, Waisi J, Khalid H, Abbas Husain AHA, Hammouda R, Khan SU, Patel BD, Sardarova N, Awosika A. Liquid or soft-gel levothyroxine vs tablet levothyroxine in athyreotic adults after total thyroidectomy: Systematic review and meta-analysis. World J Clin Cases 2026; 14(16): 119700
- URL: https://www.wjgnet.com/2307-8960/full/v14/i16/119700.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i16.119700